Skip to main content

Corient Capital Partners, LLC

SEC CIK
0001688519
Latest filing
Nov 14, 2022

ABT holding history

Abbott Laboratories in every 13F filed by Corient Capital Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q3 2022 holdings

Shares (Q3 2022)
56,753
Value
$6.17M
% of portfolio
0.5%
Quarters held
7
Since Q1 2021
Holdings of ABT by Corient Capital Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202256,753$6.17M0.5%00.0%UnchangedHolders
Q2 202256,753$6.17M0.5%+1,675+3.0%AddedHolders
Q1 202255,078$6.52M0.4%+603+1.1%AddedHolders
Q4 202154,475$7.67M0.5%+825+1.5%AddedHolders
Q3 202153,650$6.34M0.5%+4,473+9.1%AddedHolders
Q2 202149,177$5.70M0.4%+4,866+11.0%AddedHolders
Q1 202144,311$5.31M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.